They showed that simultaneous disruption of IL-33, IL-25, and TSLP signaling inhibited the progression of Th2 cytokine-driven liver fibrosis but that individual disruption of each had no effect (48). This evidence concerns the gene IL33 and Hepatic fibrosis.